Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02702687 · ClinicalTrials.gov registry record · NA

Childhood Asthma Perception Study

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
363
Enrollment target

NCT02702687 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 363 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02702687, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
363 participants
Enrollment target

Study Summary

This randomized controlled trial will include Latino and Black adolescents with asthma ages 10-17 years old and their caregivers. Participants will be recruited from clinics in the Bronx, New York. The primary aims are to examine the efficacy of peak expiratory flow (PEF) prediction with feedback versus control feedback on 1) under-perception of asthma symptoms 2) controller medication adherence and 3) asthma control and emergency health care use. These aims will be examined across a 1-year follow-up. An exploratory aim examines the hypothesized pathway that the PEF intervention reduces under-perception of symptoms, shifts illness representations toward the professional model and increases adolescents' and parents' asthma management self-efficacy, resulting in greater medication adherence and improved asthma control.

Interventions

  • BEHAVIORAL PEF Feedback
  • BEHAVIORAL Control Feedback

Trial Details

FieldValue
Enrollment Target 363 participants
Start Date 2016-05
Est. Completion 2022-07-28
Phase NA

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT02702687

The ClinicalTrials.gov registry entry for NCT02702687 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 363 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PEF Feedback is the first listed.

NCT02702687 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02702687 about?

NCT02702687 is a clinical study titled "Childhood Asthma Perception Study". This randomized controlled trial will include Latino and Black adolescents with asthma ages 10-17 years old and their caregivers. Participants will be recruited from clinics in the Bronx, New York. The primary aims are to examine the efficacy of peak expiratory flow (PEF) prediction with feedback ve...

What is the current status of trial NCT02702687?

This trial is currently completed. It is a NA study. The enrollment target is 363 participants. The study started on 2016-05. Estimated completion is 2022-07-28.

What interventions are being tested in trial NCT02702687?

The interventions under investigation include: PEF Feedback (BEHAVIORAL), Control Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT02702687?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.